Merck Tbk PT (MERK.JK) Stock Price

Merck Tbk PT Price

CLOSED
3,770.00
​
Market closed

Over the last 19 years Merck Tbk PT grew revenue by 4.9% annually, reaching 1.20 T IDR. Earnings per share have grown at 5.6% per year over the last 19 years. For Merck Tbk PT, the net margin of 20.3% is up versus 12.4% a few years ago. At today's price the dividend yield works out to roughly 4.51%. The payout ratio is around 31% of earnings. The dividend has grown at 4.8% per year over the past 19 years.

Merck Tbk PT stock price

Access this data via the Eulerpool API

Merck Tbk PT business model & stock analysis

PT Merck Tbk engages in the pharmaceutical and chemical businesses. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 376 full-time employees. The firm delivers personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. The firm operates through three segments: Biopharma (ethical products), Consumer Health (over-the-counter products) and Others.

Frequently asked questions about Merck Tbk PT

Converted at the current exchange rate, the Merck Tbk PT share trades at 0.19 EUR (3,770.00 IDR).

The revenue cannot currently be calculated for Merck Tbk PT.

The profit cannot currently be calculated for Merck Tbk PT.

The P/E ratio cannot be calculated for Merck Tbk PT at the moment.

The P/S cannot be calculated for Merck Tbk PT currently.

The Eulerpool Quality Score for Merck Tbk PT is 4/10.

The ISIN of Merck Tbk PT is ID1000136609. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Merck Tbk PT is MERK.JK. The ticker symbol is used to trade Merck Tbk PT shares on the stock exchange.

Fair ValueTerminal
3,996.20 IDR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
3.19 B IDR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Indonesia
Currency
IDR
Initial public offering
Jul 23, 1981
ISIN
ID1000136609
Cusip
Y60131144
Market capitalization
1.69 T IDRMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
4.18
P/B Ratio
1.73
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
24.64 %
Dividend
Dividend yield
4.51 %
Payout Ratio
31.23 %
Dividend growth Ø5Y
6.86 %
Dividend payments per year
1
Dividend paid since
6 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 10, 2026, 3:54 PM

Merck Tbk PT Peer Group

Merck Tbk PT FIGI

MERK:IJ · BBG000BDNDH6

All fundamentals and in-depth analysis of Merck Tbk PT

Our stock analysis for Merck Tbk PT stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck Tbk PT. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.